Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 1,903 shares at $16.01 ($31K) on 2023-07-10, disclosed to the SEC on 2023-07-12.
Scheduled sale ($31k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.01 | 1,202 | $19K | 63.1% |
| 2 | $16.02 | 500 | $8K | 26.2% |
| 3 | $16.23 | 201 | $3K | 10.7% |
| Total | $16.04 avg | 1,903 | $31K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |